Posts with tag: photography
Moelis & Co. (MC) beats Q4 earnings views; Adjusted Earnings: $1.18 per share; Revenue: $438.7 million
Published on: February 05, 2025, 11:09 PM UTC
Skyworks Solutions forecasts a decline in mobile segment revenue and projects profits below Wall Street estimates for the current quarter. Shares fell over 20% in extended trading.
Published on: February 05, 2025, 11:08 PM UTC
RMR Group Inc. (RMR) reports earnings of $6.3 million in fiscal Q1, with a net income of 38 cents per share.
Published on: February 05, 2025, 11:07 PM UTC
Central Garden & Pet (CENT) reports Q4 revenue of $656.4 million, beating estimates by 4.4% and posting a significant EPS beat of $0.21 vs. -$0.01 estimate. Despite sales growth of 3.5% year-on-year, analysts project flat revenue in the next 12 months. The company shows strong cash profitability with an impressive free cash flow margin of 10.5% over the past two years.
Published on: February 05, 2025, 11:01 PM UTC
The Ensign Group, Inc. (ENSG) reported $79.7 million in fourth-quarter net income, $1.36 per share. Adjusted earnings were $1.49 per share, topping estimates. Revenue reached $1.13 billion, exceeding expectations. For the year, profit was $298 million, or $5.12 per share, on revenue of $4.26 billion. ENSG projects full-year earnings of $6.16 to $6.34 per share and revenue between $4.83 billion and $4.91 billion.
Published on: February 05, 2025, 10:08 PM UTC
Alpha and Omega Semiconductor Ltd. reports a loss of $6.6 million in its fiscal second quarter, with revenue of $173.2 million. For the current quarter, Alpha and Omega expects revenue in the range of $148 million to $168 million.
Published on: February 05, 2025, 10:08 PM UTC
Globe Life Inc. (GL) announced Q4 profit of $255.2 million, topping analysts' expectations of $3.10 per share. Annual earnings reached $1.07 billion, with revenue of $5.8 billion.
Published on: February 05, 2025, 10:08 PM UTC
Align Technology (NASDAQ: ALGN) reports inline Q4 results; revenue meets expectations but next quarter's guidance disappoints. Revenue up 4% year-over-year, non-GAAP EPS in line at $2.44 per share. Despite Q4 and 2024 results, revenue guidance for Q1 2025 falls below estimates. Find out more in our full research report.
Published on: February 05, 2025, 10:04 PM UTC
Novo Nordisk (NVO) is not overly concerned about upcoming Medicare price negotiations over blockbuster GLP-1 drugs, even though the company still stands with the industry against the new practice.
Published on: February 05, 2025, 09:02 PM UTC